3/A

PRIMARY DOCUMENT

Company: ENANTA PHARMACEUTICALS INC
Filed: May 13, 2014
Period of Report: May 9, 2014
Accession Number: 0000908662-14-000181

View Document ↗ View on SEC.gov ↗